InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.14
(
-0.30%
)
Bitcoin
63,305.65
(
-1.46%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: None

Friday, 11/13/2020 5:29:38 PM

Friday, November 13, 2020 5:29:38 PM

Post# of 30990
I was blindsided by this news as I was HOPING for a phase 2 study which showed that MYMD-1 was able to at least slow the progression of Hashimoto's Disease, thus leading to an opportunity to partner with a leading pharmaceutical company for further developement. This looks like a situation where persons continuing to hold RCPIQ shares will be left out in the cold, which is the usual Wall Street outcome.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up